Promaxo Selected As A Featured Innovator at LSI 2022 Medtech Investor Summit
Promaxo, a medical technology company that develops and commercializes office-based modular MRI and MRI based technologies, is returning as a presenting company at the third annual Life Science Intelligence (LSI) USA '22 Emerging Medtech Summit.?
Life Science Intelligence, a market intelligence and consulting company focused on covering the global medtech and healthtech markets, has made its summit an annual showcase for the future of life science technologies.
It will be held at the Monarch Beach Resort in Dana Point, CA the week of March 15. Having reached capacity the event is extending virtual badges for attendance.
Showcasing the latest in market intelligence the event has attracted close to a thousand in-person attendees with over 200 presenting medtech startups being vetted by hundreds of investors and strategics.
Promaxo covers an area of medicine that has a growing problem that needs a solution.
Time, or in the case of healthcare, testing is of the essence, which is particularly difficult when the point of access is a specific testing center far removed from the doctor and patient.?
This gap is closing as remote screening and biometric devices increasingly become available in the home or doctors’ offices. Heightening the awareness of these new tools is the novel coronavirus, which has, as most crises do, revealed areas of vulnerabilities that need to be rapidly addressed.?
One area of testing vulnerability is in imaging, where access to MRIs can give doctors and patients more immediate answers to make timely decisions. Yet today the average wait time for an MRI is over a week. Some 12 million Americans are misdiagnosed each year, and nearly a third result in serious injury or death for the patient.??
“Advances in artificial intelligence and hardware are enhancing our medical imaging capabilities. We know this first hand as we are innovating on both fronts with my company Promaxo, which has developed an in-office MRI” shared President and CEO Amit Vohra, PhD, MBA.
Interest from both investors and strategics has grown in seeing new technologies applied specifically to modernizing workflows and bringing the point of care closer to the patient.?
“The strategics and investors that attend our meetings are looking for quality deal-flow and cutting edge innovators, like Promaxo. Compact and modular solutions for medical imaging are becoming a growing need in the market and we’re excited to hear from Amit on Promaxo’s growth” commented Scott Pantel, Founder and CEO of LSI.
About Promaxo, Inc.
Promaxo was founded by a team of entrepreneurs and healthcare innovators to develop a minimally-invasive and patient-centric MRI and robotic platform. Based in Oakland, California, and backed by over 200 patents, the Company’s mission is to improve lives through state-of-the-art medical imaging, robotics and AI capabilities. With a compact and adaptable MRI, Promaxo is redefining the standard of care by improving the quality and speed of patient diagnosis and interventions. The Company has formed numerous long-term and strategic partnerships with investor groups and corporation as it drives commercialization of the Promaxo MRI system.
To learn more about the technology behind the MRI system and its scope, please visit:?Promaxo.com.
Held annually in Southern California, the Emerging Medtech Summit brings together the industry’s most innovative startups, active investors, and strategic buyers so they can connect, collaborate and build the future of healthcare. Learn more at https://www.lifesciencemarketresearch.com/medtech-summit-2022.
About Life Science Intelligence (LSI)
LSI is a market intelligence & consulting company focused on covering the global medtech and healthtech markets.? We help healthcare executives make more informed strategic decisions by better understanding market dynamics, trends, opportunities, and the competitive landscape. https://www.lifesciencemarketresearch.com